OKURHealthcare
OnKure Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for OnKure Therapeutics, Inc. (OKUR), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are OKUR insiders buying or selling?
OnKure Therapeutics, Inc. insiders reported 24 open-market buys ($36.4M) and 17 sells ($5.2M) across 41 Form 4 filings — a net buying position of $31.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jun 24, 2026)
Total Form 4 filings
41
SEC EDGAR
Insider filers
15
Insider buys (24)
$36.4M
Insider sells (17)
$5.2M
Insider sentiment
Net buyingNet insider flow of $31.2M in net buying.
Recent OKUR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | Nicholas A Saccomano | President and CEO | Sale | 86 | $4.40 | $378.08 |
| Jun 24, 2026 | Jason A. Leverone | Chief Financial Officer | Sale | 303 | $4.40 | $1.3K |
| Mar 24, 2026 | Nicholas A Saccomano | President and CEO | Sale | 86 | $4.16 | $357.46 |
| Mar 24, 2026 | Jason A. Leverone | Chief Financial Officer | Sale | 301 | $4.16 | $1.3K |
| Dec 24, 2025 | Nicholas A Saccomano | President and CEO | Sale | 87 | $2.97 | $258.19 |
| Dec 24, 2025 | Jason A. Leverone | Chief Financial Officer | Sale | 302 | $2.97 | $896.25 |
| Sep 24, 2025 | Nicholas A Saccomano | President and CEO | Sale | 88 | $2.62 | $230.87 |
| Sep 24, 2025 | Jason A. Leverone | Chief Financial Officer | Sale | 303 | $2.62 | $794.92 |
| Jun 25, 2025 | Nicholas A Saccomano | President and CEO | Sale | 88 | $2.38 | $209.81 |
| Jun 25, 2025 | Jason A. Leverone | Chief Financial Officer | Sale | 303 | $2.38 | $722.41 |
| May 19, 2025 | Bihua Chen | Other | Sale | 1.8M | $1.85 | $3.4M |
| May 19, 2025 | Anders D Hove | 10% Owner | Purchase | 1.4M | $1.85 | $2.6M |
| May 14, 2025 | Bihua Chen | 10% Owner | Sale | 24.3K | $1.99 | $48.2K |
| Apr 8, 2025 | Nicholas A Saccomano | President and CEO | Sale | 874 | $2.94 | $2.6K |
| Apr 8, 2025 | Jason A. Leverone | Chief Financial Officer | Sale | 3.1K | $2.94 | $9.2K |
| Sep 26, 2024 | Braden Michael Leonard | 10% Owner | Purchase | 98.3K | $1.47 | $144.7K |
| Sep 19, 2024 | Braden Michael Leonard | 10% Owner | Purchase | 56.1K | $1.36 | $76.2K |
| Sep 16, 2024 | Braden Michael Leonard | 10% Owner | Purchase | 358.9K | $1.35 | $484.3K |
| Aug 15, 2024 | Braden Michael Leonard | 10% Owner | Purchase | 271.8K | $1.40 | $380.6K |
| May 16, 2024 | Braden Michael Leonard | 10% Owner | Purchase | 414.3K | $1.54 | $639.6K |
| Aug 29, 2023 | Ashley Hall | Chief Development Officer | Sale | 15.6K | $6.28 | $98.1K |
| Jun 23, 2023 | Novo Holdings A/S | 10% Owner | Sale | 100.0K | $7.10 | $709.7K |
| May 10, 2023 | Niall O'Donnell | Director | Purchase | 125.0K | $8.00 | $1.0M |
| Sep 2, 2022 | Michael Cruse | Chief Operating Officer | Purchase | 7.5K | $3.39 | $25.4K |
| Aug 31, 2022 | Michael Cruse | Chief Operating Officer | Purchase | 7.3K | $3.20 | $23.2K |
Showing the 25 most recent of 41 Form 4 filings for OnKure Therapeutics, Inc..
Most active OKUR insiders
- Bali Muralidhar8 filings
- Jason A. Leverone6 filings
- Nicholas A Saccomano6 filings
- Braden Michael Leonard5 filings
- Michael Cruse3 filings
Ask anything about OKUR insider activity
Use Trabud's AI agent to query OnKure Therapeutics, Inc.'s Form 4 history in plain English — "Show me OKUR CEO purchases this year" or compare it against any other ticker.
Open the AI agentOKUR insider trading FAQ
Are OnKure Therapeutics, Inc. insiders buying or selling?
Across 41 SEC Form 4 filings, OnKure Therapeutics, Inc. (OKUR) insiders reported 24 open-market purchases totaling $36.4M and 17 sales totaling $5.2M. That is a net buying position of $31.2M.
How many insiders trade OKUR stock?
15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for OnKure Therapeutics, Inc.. The most recent filing was accepted on Jun 24, 2026.
Where does Trabud get OKUR insider trading data?
All OKUR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.